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December 20101730 AbstractsConclusion: Electrical stimulation is an effective method of activating
the calf muscle pump. Enhancements of popliteal blood velocity and volume
flow are key factors in the prevention of venous stasis and DVT. Further
studies are justified to determine the stimulation rates in those with a
compromised venous system.
Blocking the Saphenofemoral Junction During Ultrasound-Guided
Foam Sclerotherapy – Assessment of a Presumed Safety-measure
Procedure
Ceulen R.P.M., Jagtman E.A., Sommer A., Teule G.J.J., Schurink G.W.H.,
Kemerink G.J. Eur J Vasc Endovasc Surg 2010;40:775-9.
Objectives: Ultrasound-guided foam sclerotherapy (UGFS) is a tech-
nique in which a mixture of sclerosing drug and gas is used to treat varicose
veins. Several authors have demonstrated transient systemic effects after
UGFS. These effects are not well understood but probably originate from a
systemic distribution of the sclerosing foam. Therefore, safety measures have
been developed to prevent foam from flowing into the deep venous system.
The aim of the study is to evaluate whether blockage of the saphenofemoral
(SF) junction by either manual compression or surgical ligation prevents
microbubbles from leaking into the deep venous circulation.
Methods: To detect the distribution of microbubbles, radioactive
pertechnetate (99mTcO4) was added to the foam solution. Initially, in vitro
trials were performed in the laboratory to investigate the effect of 99mTc on
foam stability. The time taken for foam to liquefy was measured for foam
alone and for the mixture with 99mTc. In subsequent research, eight varicose
great saphenous veins (GSVs) were treated by UGFS. In three patients, this
treatment was preceded by surgical ligation of the SF junction. In three
patients, the groin was manually compressed during UGFS. In two patients,
UGFS was performed without compression of the groin.
Results: In vitro, 99mTc did not influence foam stability; after 2.6 min
all foam had reduced to liquid, regardless of whether 99mTc had been addedReaders can access EJVES articles at http://intl.e99mTc mixture injection. However, the decrease of radioactivity was slightly
reduced when compression or ligation of the SF junction was performed.
Conclusions: Blocking the SF junction during UGFS using either
manual compression or ligation does not prevent, but may reduce the flow of
foam into the femoral vein.
Healing and Recurrence Rates Following Ultrasound-guided Foam
Sclerotherapy of Superficial Venous Reflux in Patients with Chronic
Venous Ulceration
Pang K.H., Bate G.R., Darvall K.A.L., Adam D.J., Bradbury A.W. Eur J
Vasc Endovasc Surg 2010;40:793-8.
Objectives: To determine healing and recurrence rates following ul-
trasound-guided foam sclerotherapy (UGFS) of superficial venous reflux
(SVR) in patients with healed (clinical, etiologic, anatomic and pathophys-
iologic (CEAP) classification, C5) and open (C6) chronic venous ulceration
(CVU).
Methods: Between 1 March 2005 and 31 December 2009, 130
consecutive patients (132 limbs, 49 CEAP C5, 83 C6) of median age 70
(interquartile range (IQR) 56–76) years underwent UGFS as part of their
treatment for CVU.
Results: The median (IQR) follow-up time was 16 (12–32) months.
One C6 patient moved abroad 1 week after UGFS and was lost to follow-up.
Healing was observed in 67/82 (82%) remaining C6 patients at a median
(IQR) of 1 (1–2) month following their first UGFS treatment. In 49 limbs
originally treated for C5 disease, and in 67 limbs treated for C6 that healed
following UGFS, there were five recurrent ulcers during the follow-up
period, giving a 4.9% Kaplan–Meier estimate of recurrence at 2 years. In legs
treated for C6 and C5 disease, the median (IQR) ulcer-free periods were 22
(IQR 9–32) and 14 (IQR 8–36) months, respectively.
Discussion:Healing rates following UGFS for CVU are comparable to
those reported after surgery but recurrence may be lower. UGFS is a safe,or not. In vivo trials showed that all patients showed a decrease in the
cumulative amount of 99mTc detected in the GSV following polidocanol-
clinically effective and, thus, highly attractive minimally invasive alternative
to surgery in patients with C5 and C6 disease.lsevierhealth.com/journals/ejvs/default.cfm
